Skip to main content

Advertisement

SpringerLink
Log in

MRI criteria in MS patients with negative and positive oligoclonal bands: equal fulfillment of Barkhof’s criteria but different lesion patterns

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

In multiple sclerosis (MS) more than 95% of the patients have positive oligoclonal bands (OCB) in the cerebrospinal fluid (CSF). Previous studies have reported differences between patients with and without OCB mainly with regard to clinical parameters such as age, gender, disease duration, and clinical severity. However, several MRI characteristics have also been hypothesized to be distinct, and a varying lesion load in OCB-negative and -positive patients is proposed. In this study, we aimed to evaluate whether Barkhof’s diagnostic MRI criteria are unequally frequently fulfilled in OCB-negative and -positive MS patients. We screened our database for all OCB-negative MS patients who had (1) been treated with the diagnosis of a clinical definite relapsing-remitting MS in our institution as well as (2) undergone CSF analysis and MR brain imaging during hospital stay between January 2004 and December 2007. Eleven OCB-negative patients were identified who fulfilled these criteria. In a second step, we carefully matched each of them to two OCB-positive controls according to age, gender, EDSS, and disease duration. The separate analysis of the several parameters of Barkhof’s criteria revealed a less frequent prevalence of infratentorial (3/11 vs. 18/22; P = 0.005) and a more frequent occurrence of juxtacortical lesions (10/11 vs. 10/22; P = 0.022) in OCB-negative as compared to OCB-positive patients. The overall fulfillment of the Barkhof criteria did not differ in OCB-negative and -positive patients (7/11 vs. 16/22; P = 0.696). Further analyses of MRI findings between OCB-negative and -positive MS patients might contribute to a better pathophysiological understanding of the genesis and evidence of OCB in the CSF of MS patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Andersson M, Alvarez-Cermeno J, Bernardi G, Cogato I, Fredman P, Frederiksen J, Fredrikson S, Gallo P, Grimaldi LM, Gronning M et al (1994) Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 57:897–902

    Article  PubMed  CAS  Google Scholar 

  2. Arnold DL, Matthews PM (2002) MRI in the diagnosis and management of multiple sclerosis. Neurology 58:S23–S31

    PubMed  Google Scholar 

  3. Avasarala JR, Cross AH, Trotter JL (2001) Oligoclonal band number as a marker for prognosis in multiple sclerosis. Arch Neurol 58:2044–2045

    Article  PubMed  CAS  Google Scholar 

  4. Bakshi R, Hutton GJ, Miller JR, Radue EW (2004) The use of magnetic resonance imaging in the diagnosis and long-term management of multiple sclerosis. Neurology 63:S3–S11

    PubMed  Google Scholar 

  5. Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, Polman CH, Comi G, Ader HJ, Losseff N, Valk J (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120(Pt 11):2059–2069

    Article  PubMed  Google Scholar 

  6. Bergamaschi R, Tonietti S, Franciotta D, Candeloro E, Tavazzi E, Piccolo G, Romani A, Cosi V (2004) Oligoclonal bands in Devic’s neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations. Mult Scler 10:2–4

    Article  PubMed  CAS  Google Scholar 

  7. Brex PA, Ciccarelli O, O’Riordan JI, Sailer M, Thompson AJ, Miller DH (2002) A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 346:158–164

    Article  PubMed  Google Scholar 

  8. Fukazawa T, Kikuchi S, Sasaki H, Hamada K, Hamada T, Miyasaka K, Tashiro K (1998) The significance of oligoclonal bands in multiple sclerosis in Japan: relevance of immunogenetic backgrounds. J Neurol Sci 158:209–214

    Article  PubMed  CAS  Google Scholar 

  9. Goffette S, Schluep M, Henry H, Duprez T, Sindic CJ (2004) Detection of oligoclonal free kappa chains in the absence of oligoclonal IgG in the CSF of patients with suspected multiple sclerosis. J Neurol Neurosurg Psychiatry 75:308–310

    Article  PubMed  CAS  Google Scholar 

  10. Imrell K, Landtblom AM, Hillert J, Masterman T (2006) Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct. Neurology 67:1062–1064

    Article  PubMed  Google Scholar 

  11. Kappos L, Moeri D, Radue EW, Schoetzau A, Schweikert K, Barkhof F, Miller D, Guttmann CR, Weiner HL, Gasperini C, Filippi M (1999) Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group. Lancet 353:964–969

    Article  PubMed  CAS  Google Scholar 

  12. Lee KH, Hashimoto SA, Hooge JP, Kastrukoff LF, Oger JJ, Li DK, Paty DW (1991) Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 41:657–660

    PubMed  CAS  Google Scholar 

  13. Lycklama a Nijeholt G, Barkhof F (2003) Differences between subgroups of MS: MRI findings and correlation with histopathology. J Neurol Sci 206:173–174

    Article  PubMed  Google Scholar 

  14. Lycklama G, Thompson A, Filippi M, Miller D, Polman C, Fazekas F, Barkhof F (2003) Spinal-cord MRI in multiple sclerosis. Lancet Neurol 2:555–562

    Article  PubMed  Google Scholar 

  15. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127

    Article  PubMed  CAS  Google Scholar 

  16. Mesaroc S, Drulovic J, Levic Z, Peric V (2003) Magnetic resonance findings in the brain of patients with multiple sclerosis without oligoclonal bands in the cerebrospinal fluid. Srp Arh Celok Lek 131:31–35

    Article  PubMed  Google Scholar 

  17. Mesaros S, Drulovic J, Levic Z (2003) Clinical characteristics and neurophysiologic findings in patients with multiple sclerosis without oligoclonal IgG in cerebrospinal fluid. Srp Arh Celok Lek 131:122–126

    Article  PubMed  Google Scholar 

  18. Minneboo A, Barkhof F, Polman CH, Uitdehaag BM, Knol DL, Castelijns JA (2004) Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. Arch Neurol 61:217–221

    Article  PubMed  Google Scholar 

  19. Minneboo A, Uitdehaag BM, Ader HJ, Barkhof F, Polman CH, Castelijns JA (2005) Patterns of enhancing lesion evolution in multiple sclerosis are uniform within patients. Neurology 65:56–61

    Article  PubMed  CAS  Google Scholar 

  20. Nakashima I, Fujihara K, Misu T, Fujimori J, Sato S, Takase S, Itoyama Y (2002) A comparative study of Japanese multiple sclerosis patients with and without oligoclonal IgG bands. Mult Scler 8:459–462

    Article  PubMed  CAS  Google Scholar 

  21. Nakashima I, Fujihara K, Miyazawa H, Misu T, Fujimori J, Sato S, Itoyama Y (2006) Relevance of callosal and periventricular MRI lesions to oligoclonal bands in multiple sclerosis. Acta Neurol Scand 113:125–131

    Article  PubMed  CAS  Google Scholar 

  22. Nijeholt GJ, van Walderveen MA, Castelijns JA, van Waesberghe JH, Polman C, Scheltens P, Rosier PF, Jongen PJ, Barkhof F (1998) Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. Brain 121(4):687–697

    Article  PubMed  Google Scholar 

  23. Paty DW, Oger JJ, Kastrukoff LF, Hashimoto SA, Hooge JP, Eisen AA, Eisen KA, Purves SJ, Low MD, Brandejs V et al (1988) MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 38:180–185

    PubMed  CAS  Google Scholar 

  24. Pittock SJ, McClelland RL, Mayr WT, Jorgensen NW, Weinshenker BG, Noseworthy J, Rodriguez M (2004) Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study. Ann Neurol 56:303–306

    Article  PubMed  Google Scholar 

  25. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O’Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 58:840–846

    Article  PubMed  Google Scholar 

  26. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227–231

    Article  PubMed  CAS  Google Scholar 

  27. Reiber H (1994) Flow rate of cerebrospinal fluid (CSF)—a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci 122:189–203

    Article  PubMed  CAS  Google Scholar 

  28. Reiber H, Peter JB (2001) Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci 184:101–122

    Article  PubMed  CAS  Google Scholar 

  29. Reiber H, Sindic CJM, Thompson EJ (2006) Cerebrospinal fluid—clinical neurochemistry of neurological diseases. Springer-Verlag, Heidelberg, Germany

    Google Scholar 

  30. Reiber H, Ungefehr S, Jacobi C (1998) The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler 4:111–117

    PubMed  CAS  Google Scholar 

  31. Tas MW, Barkhol F, van Walderveen MA, Polman CH, Hommes OR, Valk J (1995) The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis. AJNR Am J Neuroradiol 16:259–264

    PubMed  CAS  Google Scholar 

  32. Tintore M, Rovira A, Martinez MJ, Rio J, Diaz-Villoslada P, Brieva L, Borras C, Grive E, Capellades J, Montalban X (2000) Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol 21:702–706

    PubMed  CAS  Google Scholar 

  33. Tintore M, Rovira A, Rio J, Nos C, Grive E, Sastre-Garriga J, Pericot I, Sanchez E, Comabella M, Montalban X (2003) New diagnostic criteria for multiple sclerosis: application in first demyelinating episode. Neurology 60:27–30

    PubMed  CAS  Google Scholar 

  34. Tintore M, Rovira A, Rio J, Nos C, Grive E, Tellez N, Pelayo R, Comabella M, Sastre-Garriga J, Montalban X (2006) Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology 67:968–972

    Article  PubMed  CAS  Google Scholar 

  35. Tintore M, Rovira A, Rio J, Tur C, Pelayo R, Nos C, Tellez N, Perkal H, Comabella M, Sastre-Garriga J, Montalban X (2008) Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology 70:1079–1083

    Article  PubMed  CAS  Google Scholar 

  36. Villar LM, Masjuan J, Gonzalez-Porque P, Plaza J, Sadaba MC, Roldan E, Bootello A, Alvarez-Cermeno JC (2002) Intrathecal IgM synthesis in neurologic diseases: relationship with disability in MS. Neurology 58:824–826

    PubMed  CAS  Google Scholar 

  37. Villar LM, Masjuan J, Gonzalez-Porque P, Plaza J, Sadaba MC, Roldan E, Bootello A, Alvarez-Cermeno JC (2003) Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis. Ann Neurol 53:222–226

    Article  PubMed  CAS  Google Scholar 

  38. Villar LM, Masjuan J, Sadaba MC, Gonzalez-Porque P, Plaza J, Bootello A, Alvarez-Cermeno JC (2005) Early differential diagnosis of multiple sclerosis using a new oligoclonal band test. Arch Neurol 62:574–577

    Article  PubMed  Google Scholar 

  39. Zeman AZ, Kidd D, McLean BN, Kelly MA, Francis DA, Miller DH, Kendall BE, Rudge P, Thompson EJ, McDonald WI (1996) A study of oligoclonal band negative multiple sclerosis. J Neurol Neurosurg Psychiatry 60:27–30

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of Erlangen-Nuremberg, Schwabachanlage 6, 91054, Erlangen, Germany

    Hagen B. Huttner, Peter D. Schellinger, Teresa Bassemir, Mathias Mäurer, Stefan Schwab & Martin Köhrmann

  2. Department of Neuroradiology, University of Erlangen-Nuremberg, Erlangen, Germany

    Tobias Struffert, Gregor Richter, Tobias Engelhorn, Meritxell Garcia & Arnd Doerfler

Authors
  1. Hagen B. Huttner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter D. Schellinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tobias Struffert
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gregor Richter
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tobias Engelhorn
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Teresa Bassemir
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mathias Mäurer
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Meritxell Garcia
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Stefan Schwab
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Martin Köhrmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Arnd Doerfler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hagen B. Huttner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huttner, H.B., Schellinger, P.D., Struffert, T. et al. MRI criteria in MS patients with negative and positive oligoclonal bands: equal fulfillment of Barkhof’s criteria but different lesion patterns. J Neurol 256, 1121–1125 (2009). https://doi.org/10.1007/s00415-009-5081-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-009-5081-y

Keywords

Search

Navigation